Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Life Sci ; 89(21-22): 773-8, 2011 Nov 21.
Article in English | MEDLINE | ID: mdl-21958470

ABSTRACT

AIMS: Excessive production of nitric oxide (NO) and reactive oxygen species (ROS) in sepsis modulates different cell functions. Since the sepsis severity is associated with the degree of platelet activation, we decided to investigate the role of systemic generation of NO and ROS in modulating the platelet adhesion of lipopolysaccharide (LPS)-treated rats. MAIN METHODS: Platelet adhesion was evaluated using fibrinogen-coated 96-well microtiter plates. Cyclic GMP levels were measured using enzyme immunoassay kit. KEY FINDINGS: Treatment of rats with LPS significantly increased spontaneous platelet adhesion, but reduced the thrombin-activated platelet adhesion when compared with control rats. Chronic treatment of rats with the NO synthase inhibitor L-NAME (20 mg/rat/day, 7 days) prior to LPS injection normalized the increased adhesion in non-activated platelets, but failed to affect the adhesion in thrombin-activated platelets. The cGMP levels were modified neither in non-activated nor in thrombin-activated platelets of LPS-treated rats when compared with control rats. The incubation of non-activated platelets with the O2- scavenger PEG-SOD reversed the stimulatory effect of LPS on spontaneous adhesion, but had no effect in stimulated-platelet adhesion of non-treated or LPS-treated groups. Moreover, pretreatment of rats with the antioxidant N-acetylcysteine (NAC; 150 mg/kg) prevented the increase of non-activated platelet adhesion, and significantly reduced the inhibitory effect of LPS on thrombin-stimulated adhesion. SIGNIFICANCE: Our findings suggest that in LPS-treated rats, NO plays an important modulatory role only in non-stimulated platelet adhesion through cGMP-independent mechanisms, while ROS, directly or by affecting the redox state of the animals, modulates both non-activated and thrombin-activated platelet adhesion.


Subject(s)
Blood Platelets/drug effects , Fibrinogen/physiology , Lipopolysaccharides/pharmacology , Platelet Adhesiveness/drug effects , Reactive Nitrogen Species/metabolism , Reactive Oxygen Species/metabolism , Acetylcysteine/pharmacology , Animals , Cyclic GMP/metabolism , Enzyme Inhibitors/pharmacology , Free Radical Scavengers/pharmacology , In Vitro Techniques , Male , NG-Nitroarginine Methyl Ester/pharmacology , Polyethylene Glycols/pharmacology , Rats , Superoxide Dismutase/pharmacology , Thrombin/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...